Triple therapy with first-generation protease inhibitors for patients with genotype 1 chronic hepatitis C: recommendations of the Italian association for the study of the liver (AISF)
about
Individualized treatment of genotype 1 naïve patients: an Italian multicenter field practice experience.Direct-acting antivirals for chronic hepatitis C.Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens.Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals.Direct-acting antivirals for chronic hepatitis C
P2860
Triple therapy with first-generation protease inhibitors for patients with genotype 1 chronic hepatitis C: recommendations of the Italian association for the study of the liver (AISF)
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Triple therapy with first-gene ...... the study of the liver (AISF)
@ast
Triple therapy with first-gene ...... the study of the liver (AISF)
@en
Triple therapy with first-gene ...... the study of the liver (AISF)
@nl
type
label
Triple therapy with first-gene ...... the study of the liver (AISF)
@ast
Triple therapy with first-gene ...... the study of the liver (AISF)
@en
Triple therapy with first-gene ...... the study of the liver (AISF)
@nl
prefLabel
Triple therapy with first-gene ...... the study of the liver (AISF)
@ast
Triple therapy with first-gene ...... the study of the liver (AISF)
@en
Triple therapy with first-gene ...... the study of the liver (AISF)
@nl
P2093
P50
P1476
Triple therapy with first-gene ...... the study of the liver (AISF)
@en
P2093
Alessia Ciancio
Barbara Coco
Davide Bitetto
Marco Marzioni
Maria Rendina
Paolo Caraceni
P356
10.1016/J.DLD.2013.08.243
P407
P577
2014-01-01T00:00:00Z